Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Daiichi Sankyo
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020744

« Back to Dashboard
NDA 020744 describes CUROSURF, which is a drug marketed by Chiesi Usa Inc and is included in one NDA. It is available from one supplier. Additional details are available on the CUROSURF profile page.

The generic ingredient in CUROSURF is poractant alfa. One supplier is listed for this compound. Additional details are available on the poractant alfa profile page.

Summary for NDA: 020744


Pharmacology for NDA: 020744

Mechanism of ActionSurfactant Activity
Physiological EffectAlveolar Surface Tension Reduction

Suppliers and Packaging for NDA: 020744

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
poractant alfa
SUSPENSION;INTRATRACHEAL 020744 NDA Chiesi USA, Inc. 10122-510 10122-510-01 1.5 mL in 1 VIAL, GLASS (10122-510-01)
poractant alfa
SUSPENSION;INTRATRACHEAL 020744 NDA Chiesi USA, Inc. 10122-510 10122-510-03 3 mL in 1 VIAL, GLASS (10122-510-03)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INTRATRACHEALStrength80MG/ML
Approval Date:Nov 18, 1999TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
US Department of Justice
Chinese Patent Office
Queensland Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus